Home / Expertise / Life Sciences & Healthcare
side view of scientist looking into microscope in bright research lab

Life Sciences & Healthcare

Italy

CMS Adonnino Ascoli & Cavasola Scamoni has developed a broad expertise in the field of life sciences. Our life sciences & healthcare practice includes the assistance of clients which operate in the fields of pharmaceuticals, biotechnology medical devices and more generally health care services. We regularly advise life science & healthcare companies on corporate governance matters and licensing and contracts, as well as day-to-day corporate issues.

Our team can count on professionals “borrowed” on a regular basis, to life sciences from other departments of the firm including team of corporate and intellectual property professionals who can boast a significant experience securing and defending patent positions and regulatory law issues in order for companies to comply with the Italian regulatory law.

Read more Read less

Choose area

Feed

07/07/2021
COV­ID-19 travel re­stric­tions for non-EU cit­izens in Italy
1. Re­quire­ments for entry from non-EU coun­tries, in­clud­ing Ukrain­i­an cit­izens Gen­er­al reg­u­la­tions for travel to and from Italy are con­tained in the DP­CM 2 March 2021 and the 14 May 2021 Or­der of the...
06/07/2021
Vac­cine com­pens­a­tion re­gimes in Italy
1. Are COV­ID-19 vac­cin­a­tions ob­lig­at­ory in your jur­is­dic­tion? Are you ex­pect­ing any le­gis­lat­ive changes to en­able man­dat­ory vac­cines for all or cer­tain people (e.g. health­care pro­fes­sion­als, pub­lic ser­vants...
Comparable
25/06/2021
Double pat­ent­ing: leg­al fact or fic­tion? (G4/19)
The En­larged Board of Ap­peal (EBA) has this week re­leased its de­cision re­gard­ing the is­sue of double pat­ent­ing. The concept of double pat­ent­ing will be fa­mil­i­ar to those work­ing in the pat­ent field. It...
17/06/2021
European Pat­ent Of­fice Ap­peal Board de­cision on ‘product-by-pro­cess’ bis­pe­cif­ic...
European Pat­ent Of­fice De­cision T0032/17 has some in­ter­est­ing points to note on the dis­clos­ure of tech­nic­al fea­tures con­ferred by hy­bridoma de­pos­it in­form­a­tion and the bur­den of proof in re­la­tion to product-by-pro­cess...
16/06/2021
EDPB ap­proves first EU GDPR Code of Con­duct for Cloud Ser­vice Pro­viders
Fol­low­ing the sub­mis­sion by the Bel­gian Data Pro­tec­tion Au­thor­ity, on May 19 the European Data Pro­tec­tion Board (EDPB) ap­proved the EU Cloud Code of Con­duct with sub­sequent fi­nal ap­prov­al by the Bel­gian...
15/06/2021
New GDPR Code of Con­duct ap­proved for Cloud In­fra­struc­ture Ser­vice Pro­viders
The European Data Pro­tec­tion Board (EDPB) and the French Data Pro­tec­tion Au­thor­ity (CNIL) ap­proved the CISPE Data Pro­tec­tion Code of Con­duct of Cloud In­fra­struc­ture Ser­vice Pro­viders in Europe (CISPE...
08/06/2021
Trade secrets in Italy
Gen­er­al 1. Has the Dir­ect­ive (EU) 2016/943 of the European Par­lia­ment and of the Coun­cil of 8 June 2016 on the pro­tec­tion of un­dis­closed know-how and busi­ness in­form­a­tion (trade secrets) against their...
Comparable
04/06/2021
Video­con­fer­ence or­al pro­ceed­ings be­fore The European Pat­ent Of­fice (G1/21)
The European Pat­ent Of­fice (EPO) was due to hear the re­fer­ral in G1/21 on Fri­day 28 May 2021 con­cern­ing the ques­tion of wheth­er the con­duct of or­al pro­ceed­ings in the form of a video­con­fer­ence is com­pat­ible...
01/06/2021
Some leaks can­'t be fixed
“Con­fid­en­tial in­form­a­tion is like an ice cube... give it to the party who has no re­fri­ger­at­or or will not agree to keep it in one, and by the time of the tri­al you have just a pool of wa­ter.” This...
14/05/2021
Re­cord­ing an as­sign­ment at the European Pat­ent Of­fice
Doc­u­ment sign­ing has presen­ted nov­el chal­lenges in the new re­mote-work­ing en­vir­on­ment. Re­cord­ing an as­sign­ment at the European Pat­ent Of­fice (EPO) can be straight­for­ward provided that the form­al re­quire­ments...
13/05/2021
Can­nabis law and le­gis­la­tion in Italy
Med­ic­al use Grow­ing, selling and im­port­ing med­ic­al can­nabis is al­lowed on the con­di­tion that the au­thor­isa­tion of the Min­istry of Health is ob­tained. Cul­tiv­a­tion, sale and im­port are cur­rently mainly...
04/05/2021
With Il­lu­mina ac­tion, court to test EU Com­mis­sion's new mer­ger re­fer­ral...
On 29 April 2021, the US life sci­ences com­pany Il­lu­mina con­firmed that it filed an ac­tion be­fore the EU courts ask­ing for an an­nul­ment of the European Com­mis­sion’s de­cision of 19 April 2021 to ac­cept...